FDA offers guidance on financial disclosures under Sunshine Act

03/7/2013 | MassDevice.com (Boston)

The FDA has issued draft guidance governing financial disclosures mandated by the Sunshine Act, which will go into effect Aug. 1. The document explains how manufacturers should report financial ties with doctors when applying for FDA marketing approval, which of those relationships should be reported and how bias is established.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Food & Drug Associate
Confidential
Washington, D.C., DC